DEPOMED INC
10-Q, EX-27.1, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: DEPOMED INC, 10-Q, 2000-08-14
Next: SCB COMPUTER TECHNOLOGY INC, 10-K, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY INFORMATION EXTRACTED FROM DEPOMED, INC.'S
BALANCE SHEET (UNAUDITED) FOR JUNE 30, 2000 AND STATEMENT OF INCOME (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             APR-01-2000             JAN-01-2000
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                       2,621,286               2,621,286
<SECURITIES>                                 2,999,455               2,999,455
<RECEIVABLES>                                  585,562                 585,562
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                               121,550                 121,550
<PP&E>                                       1,443,212               1,443,212
<DEPRECIATION>                               (579,994)               (579,994)
<TOTAL-ASSETS>                               7,484,827               7,484,827
<CURRENT-LIABILITIES>                        1,697,272               1,697,272
<BONDS>                                              0                       0
                                0                       0
                                 12,386,000              12,386,000
<COMMON>                                    19,731,149              19,731,149
<OTHER-SE>                                           0                       0
<TOTAL-LIABILITY-AND-EQUITY>                 7,484,827               7,484,827
<SALES>                                              0                       0
<TOTAL-REVENUES>                               585,562                 961,980
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                             2,210,099               3,985,453
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              16,013                  33,712
<INCOME-PRETAX>                            (2,179,212)             (3,826,666)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                        (2,179,212)             (3,826,666)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                               (2,179,212)             (3,826,666)
<EPS-BASIC>                                     (0.33)                  (0.59)
<EPS-DILUTED>                                   (0.33)                  (0.59)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission